DEXAMETHASONE PO4, MOXIFLOXACIN HCL, BROMFENAC SODIUM SESQUIHYDRATE 0.1% / 0.5% / 0.007% OMNI BY OCULAR SCIENCE Trademark
Trademark Overview
On Thursday, May 4, 2017, a trademark application was filed for DEXAMETHASONE PO4, MOXIFLOXACIN HCL, BROMFENAC SODIUM SESQUIHYDRATE 0.1% / 0.5% / 0.007% OMNI BY OCULAR SCIENCE with the United States Patent and Trademark Office. The USPTO has given the DEXAMETHASONE PO4, MOXIFLOXACIN HCL, BROMFENAC SODIUM SESQUIHYDRATE 0.1% / 0.5% / 0.007% OMNI BY OCULAR SCIENCE trademark a serial number of 87437595. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 25, 2018. This trademark is owned by Ocular Science, Inc.. The DEXAMETHASONE PO4, MOXIFLOXACIN HCL, BROMFENAC SODIUM SESQUIHYDRATE 0.1% / 0.5% / 0.007% OMNI BY OCULAR SCIENCE trademark is filed in the Pharmaceutical Products category with the following description:
Ophthalmic preparations
General Information
Serial Number | 87437595 |
Word Mark | DEXAMETHASONE PO4, MOXIFLOXACIN HCL, BROMFENAC SODIUM SESQUIHYDRATE 0.1% / 0.5% / 0.007% OMNI BY OCULAR SCIENCE |
Filing Date | Thursday, May 4, 2017 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, June 25, 2018 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, September 26, 2017 |
Trademark Statements
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Disclaimer with Predetermined Text | "DEXAMETHASONE PO4, MOXIFLOXACIN HCL, BROMFENAC SODIUM SESQUIHYDRATE 0.1% / 0.5% / 0.007%" AND "OCULAR SCIENCE" |
Description of Mark | The mark consists of the words "Dexamethasone PO4, Moxifloxacin HCl, Bromfenac Sodium Sesquihydrate 0.1% / 0.5% / 0.007%" above the words of "OMNI by OCULAR SCIENCE". The "Dexamethasone PO4, Moxifloxacin" words are above the "HCl, Bromfenac Sodium" words. The "HCl, Bromfenac Sodium" words are above the "Sesquihydrate" word. The "Sesquihydrate" word is above the "0.1% / 0.5% / 0.007%" words. The "Dexamethasone PO4, Moxifloxacin HCl, Bromfenac Sodium Sesquihydrate 0.1% / 0.5% / 0.007%" words are superimposed over a background of stripes. The word "OMNI" is above the words "by OCULAR SCIENCE". The words "by OCULAR SCIENCE" is centered with respect to "OMNI". The lettering for "OMNI" is larger than the lettering for "by OCULAR SCIENCE". There is a shaded circle behind the letter "M" in "OMNI". There is a top arc that begins between the "O" and the "M" of "OMNI" and arcs towards the right ending to the right of the "I" in "OMNI". There is a bottom arc that begins at the "N" in "OMNI" and then arcs towards the left ending to the left of the "O" in "OMNI". |
Goods and Services | Ophthalmic preparations |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, May 10, 2017 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Ocular Science, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Los Angeles, CA 90025 |
Party Name | Ocular Science, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Los Angeles, CA 90025 |
Trademark Events
Event Date | Event Description |
Monday, June 25, 2018 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
Monday, June 25, 2018 | ABANDONMENT - NO USE STATEMENT FILED |
Tuesday, November 21, 2017 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, September 26, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, September 26, 2017 | PUBLISHED FOR OPPOSITION |
Wednesday, September 6, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Thursday, August 10, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, August 8, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, August 7, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, August 7, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Sunday, August 6, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Sunday, August 6, 2017 | NON-FINAL ACTION E-MAILED |
Sunday, August 6, 2017 | NON-FINAL ACTION WRITTEN |
Tuesday, August 1, 2017 | ASSIGNED TO EXAMINER |
Thursday, May 11, 2017 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Wednesday, May 10, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Monday, May 8, 2017 | NEW APPLICATION ENTERED IN TRAM |